The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -2,958 | 4,166 | 8,713 | - |
| Stock-based compensation | 401 | 368 | 432 | 342 |
| Net change in fair value of trading marketable securities | - | 0 | 0 | 0 |
| Net loss | - | - | - | -5,593 |
| Net change in fair value of digital assets | - | -13 | 75 | - |
| Net change in fair value of derivative liability | -146 | - | - | - |
| Non-cash lease expense | 9 | 9 | 9 | 17 |
| Loss on extinguishment of debt | - | 825 | - | - |
| Loss on extinguishment of debt - related party | - | 333 | - | - |
| Amortization of debt discounts and debt issuance costs | 69 | 9 | 83 | 54 |
| Amortization of debt discounts and debt issuance costs - related party | 18 | 62 | - | - |
| Prepaid expenses and other current assets | 54 | -18 | -53 | -58 |
| Deferred offering costs | 0 | - | - | - |
| Accounts payable and accrued liabilities | 1,029 | -832 | -906 | 3,046 |
| Accounts payable - related parties | 123 | 312 | 7 | -36 |
| Accrued interest | 30 | 2 | 28 | 18 |
| Accrued interest - related parties | 6 | 21 | - | - |
| Advances from investors | 0 | - | - | - |
| Fixed cash payments related to operating leases | -10 | -9 | -9 | -17 |
| Investment in trading marketable securities | - | - | 0 | 0 |
| Net cash used in operating activities | -1,191 | -2,911 | -3,498 | -2,111 |
| Proceeds from disposition of marketable securities | - | 0 | 0 | 0 |
| Purchase of digital assets | - | 0 | 250 | - |
| Proceeds from disposition of digital assets | - | -188 | - | - |
| Net cash (used in) provided by investing activities | - | 188 | -250 | 0 |
| Proceeds from issuance of common shares for cash, net | 10,033 | 1,760 | 3,312 | 1,079 |
| Proceeds from issuance of convertible notes, net | 593 | -318 | 0 | 737 |
| Proceeds from issuance of convertible notes, net - related party | - | 189 | - | - |
| Proceeds from exercise of warrants | 234 | 0 | 132 | - |
| Repayment of convertible note | - | 24 | - | - |
| Net cash provided by financing activities | 10,860 | 1,607 | 3,444 | 1,816 |
| Effect of exchange rate changes on cash | 4 | -4 | -42 | 23 |
| Net change in cash and cash equivalents | 9,673 | -1,120 | -346 | -272 |
| Cash and cash equivalents - beginning of period | 600 | 1,720 | 2,338 | - |
| Cash and cash equivalents - end of period | 10,273 | 600 | 1,720 | - |
ARTELO BIOSCIENCES, INC. (ARTL)
ARTELO BIOSCIENCES, INC. (ARTL)